Larissa J. Vos

1.3k citations

31 papers · 976 indexed · h-index 16

Molecular Biology
Cardiology and Cardiovascular Medicine top 10%
Oncology top 10%
Cancer Research top 10%
Pulmonary and Respiratory Medicine

Co-authors: John R. Mackey Gordon K. Chan Jakub K. Famulski Sunita Ghosh Edith Pituskin D. Ian Paterson Davinder S. Jassal Mark J. Haykowsky
Topics: Microtubule and mitosis dynamics (4 papers)Prostate Cancer Diagnosis and Treatment (4 papers)Prostate Cancer Treatment and Research (4 papers)
Cited by: Cardiology and Cardiovascular Medicine Cancer Research Oncology
Journals: Journal of Clinical Oncology The Journal of Cell Biology PLoS ONE
Partner nations: Canada United States Netherlands

In The Last Decade

Larissa J. Vos

31 papers receiving 961 citations

Peers

Countries citing papers authored by Larissa J. Vos

Since Specialization

Citations

This map shows the geographic impact of Larissa J. Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larissa J. Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larissa J. Vos more than expected).

Fields of papers citing papers by Larissa J. Vos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larissa J. Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larissa J. Vos. The network helps show where Larissa J. Vos may publish in the future.

Co-authorship network of co-authors of Larissa J. Vos

This figure shows the co-authorship network connecting the top 25 collaborators of Larissa J. Vos. A scholar is included among the top collaborators of Larissa J. Vos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larissa J. Vos. Larissa J. Vos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chemotherapy-induced weight gain in early-stage breast cancer: a prospective matched cohort study reveals associations with inflammation and gut dysbiosis 2023 ·BMC Medicine ·John Walker,Anil A. Joy,Larissa J. Vos,Trevor H. Stenson,John R. Mackey,Juan Jovel,Dina Kao,Karen Madsen,Gane Ka‐Shu Wong	10
2	Clinical Outcomes of the CHIRP Trial: A Phase II Prospective Randomized Trial of Conventionally Fractionated Versus Moderately Hypofractionated Prostate and Pelvic Nodal Radiation Therapy in Patients With High-Risk Prostate Cancer 2021 ·Practical Radiation Oncology ·Michael H. Wang,Larissa J. Vos,Don Yee,Samir Patel,Nadeem Pervez,Matthew Parliament,Nawaid Usmani,Brita Danielson,John Amanie,R. Pearcey,Sunita Ghosh,Colin Field,B. G. Fallone,Albert Murtha	8
3	Uridine Glucuronosyltransferase 2B7 Polymorphism-Based Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy for Early-Stage Breast Cancer 2021 ·Clinical Breast Cancer ·Anil A. Joy,Larissa J. Vos,Edith Pituskin,Sarah F. Cook,Robert R. Bies,(unknown),Karen King,Sanraj Basi,Judith Meza–Junco,John R. Mackey,Avalyn Stanislaus,Vijaya L. Damaraju,Sambasivarao Damaraju,Michael B. Sawyer	3
4	Skin Toxicity in Early Breast Cancer Patients Treated with Field-In-Field Breast Intensity-Modulated Radiotherapy versus Helical Inverse Breast Intensity-Modulated Radiotherapy: Results of a Phase III Randomised Controlled Trial 2020 ·Clinical Oncology ·Kurian Joseph,Larissa J. Vos,Zsolt Gabos,Nadeem Pervez,Susan Chafe,Keith Tankel,Heather Warkentin,Sunita Ghosh,John Amanie,(unknown),(unknown),(unknown),M. Mackenzie,Siham Sabri,Matthew Parliament,John R. Mackey,Bassam Abdulkarim	22
5	Adjuvant breast radiotherapy, endocrine therapy, or both after breast conserving surgery in older women with low-risk breast cancer: Results from a population-based study 2020 ·Radiotherapy and Oncology ·Kurian Joseph,(unknown),Verònica Alba,(unknown),(unknown),Larissa J. Vos,Sunita Ghosh,Aswin Abraham,Susan Chafe,Ericka Wiebe,Hongwei Liu,Carole Chambers,Zsolt Gabos,Keith Tankel,Sasha Lupichuk,Karen King	17
6	A population-based study examining the influence of a specialized rapid-access cancer clinic on initial treatment choice in localized prostate cancer 2018 ·Canadian Urological Association Journal ·Larissa J. Vos,Clement Ho,Bryan Donnelly,(unknown),Marc Kerba	2
7	A multicentre, open-label phase II study of Irinotecan, capecitabine (Xeloda®), and Oxaliplatin (IXO) as first-line treatment in patients with metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma 2018 ·Investigational New Drugs ·(unknown),Karen Mulder,Christine Brezden‐Masley,Michael M. Vickers,Jose Gerard Monzon,Hagen F. Kennecke,Rakesh Goel,Larissa J. Vos,Sunita Ghosh,(unknown),Anthony Fields,Jean A. Maroun,Jennifer L. Spratlin	1
8	Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101–Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity 2017 ·Journal of Clinical Oncology ·Edith Pituskin,John R. Mackey,Sheri L. Koshman,Davinder S. Jassal,Marshall Pitz,Mark J. Haykowsky,Joseph J. Pagano,Kelvin Chow,Richard B. Thompson,Larissa J. Vos,Sunita Ghosh,Gavin Y. Oudit,Justin A. Ezekowitz,D. Ian Paterson	253
9	Patient reported quality of life after helical IMRT based concurrent chemoradiation of locally advanced anal cancer 2016 ·Radiotherapy and Oncology ·Kurian Joseph,Larissa J. Vos,Heather Warkentin,Kim Paulson,(unknown),Nawaid Usmani,Keith Tankel,Diane Severin,Tirath Nijjar,Dan Schiller,Clarence Wong,Sunita Ghosh,Karen Mulder,Colin Field	33
10	Role of serial multiparametric magnetic resonance imaging in prostate cancer active surveillance 2016 ·World Journal of Radiology ·Larissa J. Vos,(unknown),Keith Wachowicz,(unknown),(unknown),John Amanie,Nadeem Pervez,Matthew Parliament,Edith Pituskin,B. G. Fallone,Nawaid Usmani	11
11	PDGFRα Regulates Follicular Cell Differentiation Driving Treatment Resistance and Disease Recurrence in Papillary Thyroid Cancer 2016 ·EBioMedicine ·Ana Lopez-Campistrous,(unknown),Matthew G.K. Benesch,(unknown),Raymond Lai,Aducio Thiesen,Jay Dewald,Peng Wang,Karen Chu,Sunita Ghosh,David Williams,Larissa J. Vos,David N. Brindley,Todd McMullen	27
12	100: A Phase III Randomized Control Trial Comparing Skin Sparing Helical Tomotherapy to 3D-Conformal Radiotherapy for Adjuvant Radiotherapy of Early Stage Breast Cancer 2016 ·Radiotherapy and Oncology ·Kurian Joseph,Bassam Abdulkarim,Larissa J. Vos,Heather Warkentin,Zsolt Gabos,Nadeem Pervez,Keith Tankel,Sunita Ghosh,Susan Chafe,John Amanie,Colin Field,Matthew Parliament	1
13	A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast Cancer 2015 ·Clinical Breast Cancer ·Michael B. Sawyer,Edith Pituskin,Sambasivarao Damaraju,Robert R. Bies,Larissa J. Vos,Carla M. Prado,Michelle Kuzma,Andrew Scarfe,Mark Clemons,Katia Tonkin,Heather‐Jane Au,Sheryl Koski,Anil A. Joy,Michael Smylie,Karen King,(unknown),Vijaya L. Damaraju,John Hanson,Carol E. Cass,John R. Mackey	17
14	Targeting lysyl oxidase for molecular imaging in breast cancer 2015 ·Breast Cancer Research ·Melinda Wuest,(unknown),Sai Kiran Sharma,Susan Richter,Ingrit Hamann,Monica Wang,Larissa J. Vos,John R. Mackey,Frank Wuest,Reik Löser	28
15	Role for <sup>11</sup>C-choline PET in active surveillance of prostate cancer 2015 ·Canadian Urological Association Journal ·(unknown),Larissa J. Vos,William Makis,François-Alexandre Buteau,Nadeem Pervez,Matthew Parliament,Alexander McEwan,Nawaid Usmani	3
16	A Machine Learned Classifier That Uses Gene Expression Data to Accurately Predict Estrogen Receptor Status 2013 ·PLoS ONE ·(unknown),Larissa J. Vos,Nasimeh Asgarian,Jean Deschênes,Kathryn Graham,John R. Mackey,Russell Greiner	14
17	Correction: Dynein/Dynactin-Mediated Transport of Kinetochore Components off Kinetochores and onto Spindle Poles Induced by Nordihydroguaiaretic Acid 2011 ·PLoS ONE ·Jakub K. Famulski,Larissa J. Vos,J. B. Rattner,Gordon K. Chan	2
18	Zwint-1 is a novel Aurora B substrate required for the assembly of a dynein-binding platform on kinetochores 2011 ·Molecular Biology of the Cell ·(unknown),Jason R. Bader,Patricia S. Vaughan,Sinji Borges Ferreira Tauhata,Michael Winding,Meghan A. Morrissey,Michelle V. Joyce,Bill Boggess,Larissa J. Vos,Gordon K. Chan,Edward H. Hinchcliffe,Kevin T. Vaughan	43
19	Dynein/Dynactin-Mediated Transport of Kinetochore Components off Kinetochores and onto Spindle Poles Induced by Nordihydroguaiaretic Acid 2011 ·PLoS ONE ·Jakub K. Famulski,Larissa J. Vos,J. B. Rattner,Gordon K. Chan	32
20	How to build a centromere: from centromeric and pericentromeric chromatin to kinetochore assemblyThis paper is one of a selection of papers published in this Special Issue, entitled 27th International West Coast Chromatin and Chromosome Conference, and has undergone the Journal's usual peer review process. 2006 ·Biochemistry and Cell Biology ·Larissa J. Vos,Jakub K. Famulski,Gordon K. Chan	33

About Larissa J. Vos

Larissa J. Vos is a scholar working on Oncology, Cancer Research and Radiation, having authored 31 papers that have together received 976 indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (4 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Prostate Cancer Treatment and Research (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (279 citations), Cancer Research (182 citations) and Oncology (276 citations). Larissa J. Vos has collaborated with scholars based in Canada, United States and Netherlands. Frequent co-authors include John R. Mackey, Gordon K. Chan, Jakub K. Famulski, Sunita Ghosh, Edith Pituskin, D. Ian Paterson, Davinder S. Jassal, Mark J. Haykowsky, Gavin Y. Oudit and Kelvin Chow. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Cell Biology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact